The role of procalcitonin and N-terminal pro-B-type natriuretic peptide in predicting outcome after cardiac surgery

Abstract

Objective(s): Determine the thresholds of procalcitonin (PCT) and N-terminal pro-B-type natriuretic peptide (Nt-pro-BNP) associated with poor prognosis after heart surgery with CPB. Design: Prospective observational study. Setting: Academic Medical Center Habib Bourguiba. Participants: Adult patients consecutively operated for coronary or valve surgery with CPB, elective or semi-urgent. Interventions: Serum concentrations of PCT and Nt-pro-BNP were determined before and after CPB, in the fourth postoperative hour (H4) and every day during the first 4 days. Receiver-operating characteristic curves and cut-off values were used to assess the ability of these markers to predict length of intensive care unit (ICU) stay >3 days. Measurements and Main Results: Forty patients were included in the study. Systemic inflammatory response syndrome (SIRS) occurred in 35 (87.5%) patients. Seventeen of them (42.5%) showed severe SIRS. Significantly higher serum concentrations of Nt-pro-BNP and PCT were found in patients with severe SIRS. Receiver operating characteristic (ROC) analysis showed that the threshold of PCT was 0.737 ng/mL and that of Nt-pro-BNP was 1235 pg/mL on day 1 could predict an ICU stay of more than 3 days. The association of Nt-pro-BNP to procalcitonin (p=0.009) better predicted the ICU stay than PCT alone (p=0.02) or Nt-pro-BNP alone (p=0.03). The best combination is Nt-pro-BNP + PCT + C-reactive protein (CRP) (p=0.007). Conclusions: PCT and Nt-pro-BNP on day 1 may be associated with severe SIRS and predict the length of stay. A biomarker approach combining PCT, CRP and BNP is superior to a traditional single marker for predicting ICU stay.

Keywords

pro-brain natriuretic peptide procalcitonin severe SIRS ICU stay heart surgery

Get full access to this article

View all access options for this article.

References

Aouifi

Piriou

Blanc

. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anesth 1999; 83: 602–607

Kerbaul

Guidon

Lejeune

Mollo

Mesana

Gouin

. Hyperprocalcitonemia is related to postoperative severe SIRS associated with coronary artery bypass grafting. J Cardiothorac Vasc Anesth 2002; 16: 47–53

Wan

Leclerc

Vincent

. Inflammatory response to cardiopulmonary bypass. Mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676–692

Fransen

Messen

Dentener

Senden

Geskes

Buurman

. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 1998; 111: 1290–1295

Menasché

. The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr Opin Cardiol 1995; 10: 597–604

Fagon

Chastre

Novara

Medioni

Gilbert C

. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 1993; 19: 137–144

Lemos JA

Morrow

. Brain natriuretic peptide in acute coronary syndromes. Ready for clinical application? Circulation 2002; 106: 2868–2870

Lemos JA

Morrow

Bentley

. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Eng J Med 2002; 345: 1014–1021

Selvais

Donckier

Robert

. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influence of left ventricular dysfunction and coronary artery diseases on cardiac hormonal activation. Eur J Clin Invest 1998; 28: 636–642

10.

Wieczorek

Christenson

. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 2002; 144: 834–839

11.

Hutfless

Kazanegra

Madani

. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004; 43(10): 1873– 1879.

12.

Provenchère

Berroeta

Reynaud

. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006; 34: 995–1000.

13.

Jacobs

Lund

Potts

Bell

Habener

. Procalcitonin is a glycoprotein. J Biol Chem 1981; 256: 2803–2807

14.

Harbarth

Holeckova

Froidevaux

. Geneva Sepsis Network: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396–402

15.

Cleys

Vinken

Spapen

. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002; 30: 758–762

16.

Lecharny

Khater

Bronchard

. Hyper procalcitonemia in patients with perioperative myocardial infarction after cardiac surgery. Crit Care Med 2001; 29: 323–325

17.

Dorge

Schondube

Dorge

Seipelt

Voss

Messmer

. Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thorac Cardiovasc Surg 2003; 51: 322–326

18.

Sponholz

Sakr

Reinhart

Brunkhorst

. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 2006; 10: R145. (review)

19.

Kilger

Pichler

Goetz

. Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting. Thorac Cardiovasc Surg 1998; 46: 130–133

20.

Cremer

Martin

Redl

. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61: 1714– 1720.

21.

Hall

Stafford Smith

Rocker

. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic and pharmacological considerations. Anesth Analg 1997; 85: 766– 782

22.

Messent

Sullvan

Keogh

Morgan

Evans

. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anesthesia 1992; 47: 267–268.

23.

Menasché

. The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr Opin Cardiol 1995; 10: 597–604.

24.

Hensel

Volk

Docke

. Hyperprocalcitonemia in patients with SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1988; 89: 93–104.

25.

Boeken

Feindt

Micek

Petzold

Schulte

Gams

. Procalcitonin (PCT) in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX). Cardiovasc Surg 2000; 8: 550–554.

26.

Assicot

Gendrel

Carsin

Raymond

Guilbaud

Bohuon

. High serum procalcitonin concentrations in patients with sepsis and infection. The Lancet 1993; 341: 515–518

27.

Ugarte

Silva

Mercan

De Mendonc

Vincent

. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498–504

28.

Carsin

Assicot

Feger

. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury. Burns 1997; 23: 218–224

29.

Mimoz

Benoist

Edouard

Assicot

Bohuon

Samii

. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24: 185–188

30.

Meisner

Rauschmayer

Schmidt

. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 2002; 28; 1094–1102

31.

Selvais

Donckier

Robert

32.

Wieczorek

Christenson

. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 2002; 144: 834–839

33.

Nakao

Mukoyama

Hosoda

. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide. Can J Physiol Pharmacol 1991; 69: 1500–1506

34.

Kilger

Pichler

Goetz

. Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting. Thorac Cardiovasc Surg 1998; 46: 130–133

35.

Crescenzi

Landoni

Bignami

. N-terminal B-natriuretic peptide after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2009; 23: 147–150.